Accordant Advisory Group Inc

Position in JNJ — Johnson & Johnson

CIK 2013499 ANNAPOLIS, MD

Position in JNJ

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$515,813

+$19,356 QoQ

Shares Held

2,031

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.44%

of 13F equity value

Holder Rank

#3,666

of 4,664 holders

Holding Since

Mar 2024

9 quarters on record

Healthcare · as of Jun 30, 2026

Accordant Advisory Group Inc holds $832,855 across 7 Drug Manufacturers - General names. JNJ ranks #1 (61.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	2,031	$515,813
2	GILD	Gilead Sciences, Inc.	875	$110,547
3	MRK	Merck & Co., Inc.	563	$72,345
4	LLY	ELI LILLY & Co	50	$59,971
5	BMY	Bristol Myers Squibb Co	980	$56,467
6	GSK	GSK plc	269	$14,100
7	PFE	Pfizer Inc	150	$3,612

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$515,813	2,031	0.0%	Shares	Sole	2026-07-27
2026-03-31	$496,457	2,031	+5.2%	Shares	Sole	2026-05-11
2025-12-31	$399,620	1,931	0.0%	Shares	Sole	2026-01-22
2025-09-30	$358,046	1,931	-0.2%	Shares	Sole	2025-10-22
2025-06-30	$295,418	1,934	-82.1%	Shares	Sole	2025-08-12
2024-12-31	$1,563,776	10,813	-0.8%	Shares	Sole	2025-01-23
2024-09-30	$1,765,805	10,896	-47.3%	Shares	Sole	2024-10-22
2024-06-30	$3,022,296	20,678	+267.4%	Shares	Sole	2024-07-19
2024-03-31	$890,293	5,628	—	Shares	Sole	2024-04-22
No filing history on record for this holder in this stock.